8 Related guidance

8 Related guidance

8.1 The Institute has issued guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

  • National Institute for Clinical Excellence (2002) Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NICE Technology Appraisal Guidance No. 33. London: National Institute for Clinical Excellence. [Replaced by NICE technology appraisal guidance 93]

8.2 The Institute has issued guidance on the use of laparoscopic surgery for colorectal cancer.

  • National Institute for Clinical Excellence (2000) Guidance on the use of laparoscopic surgery for colorectal cancer. NICE Technology Appraisal Guidance No. 17. London: National Institute for Clinical Excellence. [Replaced by NICE technology appraisal guidance 105]